United Therapeutics Corporation (UTHR)

Interest coverage

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Earnings before interest and tax (EBIT)	US$ in thousands	1,333,600	979,700	555,900	593,600	-187,600
Interest expense	US$ in thousands	59,300	32,400	18,600	23,500	44,200
Interest coverage		22.49	30.24	29.89	25.26	-4.24

December 31, 2023 calculation

Interest coverage = EBIT ÷ Interest expense
= $1,333,600K ÷ $59,300K
= 22.49

Based on the data provided, United Therapeutics Corp did not report the interest coverage ratio for the years ending on December 31, 2023, and 2020. However, the interest coverage ratio was 292.58 for the year ending on December 31, 2021, indicating that the company was able to cover its interest expenses approximately 292 times with its earnings before interest and taxes.

Without the data for 2023 and 2020, it is difficult to assess the trend in the company's ability to cover its interest expenses over the years. It is important to note that a higher interest coverage ratio typically suggests that a company is in a better position to meet its interest obligations from its operating income. Consequently, missing data points make it challenging to analyze the consistency of United Therapeutics Corp's interest coverage over the past five years.